Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
40.94
+1.19 (2.99%)
Nov 22, 2024, 4:00 PM EST - Market closed

Legend Biotech Statistics

Total Valuation

Legend Biotech has a market cap or net worth of $7.51 billion. The enterprise value is $6.64 billion.

Market Cap 7.51B
Enterprise Value 6.64B

Important Dates

The last earnings date was Tuesday, November 12, 2024, before market open.

Earnings Date Nov 12, 2024
Ex-Dividend Date n/a

Share Statistics

Legend Biotech has 183.45 million shares outstanding. The number of shares has increased by 6.16% in one year.

Current Share Class n/a
Shares Outstanding 183.45M
Shares Change (YoY) +6.16%
Shares Change (QoQ) +0.37%
Owned by Insiders (%) 0.06%
Owned by Institutions (%) 50.93%
Float 80.93M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 14.36
Forward PS 8.56
PB Ratio 6.73
P/TBV Ratio 6.74
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 12.77
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.98, with a Debt / Equity ratio of 0.31.

Current Ratio 4.98
Quick Ratio 4.86
Debt / Equity 0.31
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -15.76

Financial Efficiency

Return on equity (ROE) is -28.35% and return on invested capital (ROIC) is -14.06%.

Return on Equity (ROE) -28.35%
Return on Assets (ROA) -12.28%
Return on Capital (ROIC) -14.06%
Revenue Per Employee $284,876
Profits Per Employee -$190,651
Employee Count 1,826
Asset Turnover 0.29
Inventory Turnover 29.25

Taxes

In the past 12 months, Legend Biotech has paid $2.67 million in taxes.

Income Tax 2.67M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -28.49% in the last 52 weeks. The beta is 0.11, so Legend Biotech's price volatility has been lower than the market average.

Beta (5Y) 0.11
52-Week Price Change -28.49%
50-Day Moving Average 44.92
200-Day Moving Average 50.72
Relative Strength Index (RSI) 45.44
Average Volume (20 Days) 1,651,957

Short Selling Information

Short Interest 15.86M
Short Previous Month 11.95M
Short % of Shares Out 16.37%
Short % of Float n/a
Short Ratio (days to cover) 12.18

Income Statement

In the last 12 months, Legend Biotech had revenue of $520.18 million and -$348.13 million in losses. Loss per share was -$1.92.

Revenue 520.18M
Gross Profit -87.72M
Operating Income -351.24M
Pretax Income -287.07M
Net Income -348.13M
EBITDA -340.56M
EBIT -351.24M
Loss Per Share -$1.92
Full Income Statement

Balance Sheet

The company has $1.21 billion in cash and $346.59 million in debt, giving a net cash position of $865.81 million or $4.72 per share.

Cash & Cash Equivalents 1.21B
Total Debt 346.59M
Net Cash 865.81M
Net Cash Per Share $4.72
Equity (Book Value) 1.12B
Book Value Per Share 6.08
Working Capital 1.08B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$157.60 million and capital expenditures -$16.07 million, giving a free cash flow of -$173.67 million.

Operating Cash Flow -157.60M
Capital Expenditures -16.07M
Free Cash Flow -173.67M
FCF Per Share -$0.95
Full Cash Flow Statement

Margins

Gross margin is -16.86%, with operating and profit margins of -67.52% and -66.92%.

Gross Margin -16.86%
Operating Margin -67.52%
Pretax Margin -66.41%
Profit Margin -66.92%
EBITDA Margin -65.47%
EBIT Margin -67.52%
FCF Margin -46.21%

Dividends & Yields

Legend Biotech does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -6.16%
Shareholder Yield -6.16%
Earnings Yield -4.64%
FCF Yield -2.31%
Dividend Details

Analyst Forecast

The average price target for Legend Biotech is $81.46, which is 98.97% higher than the current price. The consensus rating is "Strong Buy".

Price Target $81.46
Price Target Difference 98.97%
Analyst Consensus Strong Buy
Analyst Count 13
Revenue Growth Forecast (5Y) 59.00%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Legend Biotech has an Altman Z-Score of 8.85 and a Piotroski F-Score of 2.

Altman Z-Score 8.85
Piotroski F-Score 2